- Age-related decrease in bone mass: Disrupted microarchitecture 
- Male: female ratio is 1:4 
- Can lead to fractures: vertebral body > hip > wrist fractures - wrist fractures occur most commonly at age 50-60 years 
- vertebral fractures occur most commonly at age 60-70 years 
- hip fractures occur most commonly at age 70-80 years 
 
Treatment
- Life style modification : smoking, alcohol, physical acitivty, weight loss 
- Vit D, Calcium. - Daily calcium and Vitamin D requirements are as follows: - Age 1-3yrs - 500mg/d 
- Age 4-8yrs - 800mg/d 
- Age 9-18yrs - 1000 to 1500mg/d 
- Age >50 yrs- 1200 to 1500 mg/d calcium 
- 800-1,000 IUs Vit. D 
 
 
- Biphosphonate - Indication - T-score <2.5 at the femoral neck or spine (after exclusion of secondary causes) 
- low bone mass (T-score between -1.0 and -2.5) and - 10-year probability of a hip fracture ≥ 3% or greater or 
- 10-year probability of a major osteoporosis-related fracture ≥ 20% based on WHO algorithm 
 
 
- Oral : pamidronate, alendronate (Fosamax), risedronate (Actonel), zolendronate (Reclast), ibandronate (Boniva) 
- IV 
- side effects: Esophagitis, dysphagia, gastric ulcers, Osteonecrosis of the Jaw, atypical hip fracture (Sub-trochanteric) if taken for long time 
 
- Teriparatide (Forteo) - 1-34 amino terminal residues of parathyroid hormone (1-84) 
- given by daily subcutaneous injections in case of Severe osteoporosis/high fracture risk or vertebral fracture 
- can induce transcient hypercalcemia, dizziness, nausea, headache 
- contre indicated in Paget disease : Sarcoma 
- cumulative dose: 2 years (risk of sarcoma) 
 
- Denosumab (Prolia) - Monoclonal Ig2 against RANKL (inhibits binding of RANKL to RANK) 
- given 1 injection of 60mg every 6 months 
- For Postmenopausal women at high risk of fracture 
- side effects : nasopharyngitis, back pain, mandubular osteonecrosis ( ask for dental hygiene) 
- contre indicated in severe hypocalcemia ( pay attention in case of renal diffiency) 
 
 
             
             
             
             
             
             
            